Concepedia
Statistics
Publications
25
Citations
1.9K
H-Index
20
Active since
1978
Affiliations
Novartis (Switzerland)(Current)
University of Ngaoundéré
Université de Yaoundé I
National Institutes of Health
Sanden (Japan)
Paul L. Herrling is an author at Novartis (Switzerland) specializing in neuropharmacology, neuroscience, and life sciences.
Publications per year
1978–2020
CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]d-AP5 binding sites on brain membranes and anticonvulsant activity
J. Davies, Richard H. Evans, Paul L. Herrling et al. · Brain Research · 1986 · 310 citations
Life Sciences, Neuroscience, Pharmacology +13
Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: Evidence for its mediation by quisqualateor kainate-receptors
Paul L. Herrling · Neuroscience · 1985 · 202 citations
Life Sciences, Neuroscience, Pharmacology +14
Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel antagonist, in rodents
Lechosław Turski, Thomas Klockgether, Karl‐Heinz Sontag et al. · Neuroscience Letters · 1987 · 189 citations
Medicine, Medicinal Chemistry, Pharmacology +11
Effects of excitatory amino acids and their antagonists on membrane and action potentials of cat caudate neurones.
Paul L. Herrling, Richard Morris, T.E. Salt · The Journal of Physiology · 1983 · 181 citations
Life Sciences, Neurobiology, Neuroscience +17
Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons
Paul L. Herrling, C.D. Hull · Brain Research · 1980 · 169 citations
Life Sciences, Neurobiology, Neuroscience +14
1–5 of 25